These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25414120)

  • 1. Airway and lung remodelling in chronic pulmonary obstructive disease: a role for muscarinic receptor antagonists?
    Roth M
    Drugs; 2015 Jan; 75(1):1-8. PubMed ID: 25414120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ipratropium bromide on airway and pulmonary muscarinic receptors in a rat model of chronic obstructive pulmonary disease.
    Yao W; Wang G; Zhu H; Sun Y; Zhao M
    Chin Med J (Engl); 2001 Jan; 114(1):80-3. PubMed ID: 11779443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic receptors and their antagonists in COPD: anti-inflammatory and antiremodeling effects.
    Karakiulakis G; Roth M
    Mediators Inflamm; 2012; 2012():409580. PubMed ID: 23226927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD.
    Pera T; Zuidhof A; Valadas J; Smit M; Schoemaker RG; Gosens R; Maarsingh H; Zaagsma J; Meurs H
    Eur Respir J; 2011 Oct; 38(4):789-96. PubMed ID: 21349917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic receptors on airway mesenchymal cells: novel findings for an ancient target.
    Meurs H; Dekkers BG; Maarsingh H; Halayko AJ; Zaagsma J; Gosens R
    Pulm Pharmacol Ther; 2013 Feb; 26(1):145-55. PubMed ID: 22842340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mode of action of anticholinergics in asthma.
    Gosens R; Gross N
    Eur Respir J; 2018 Oct; 52(4):. PubMed ID: 30115613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of aclidinium bromide in a cigarette smoke-exposed Guinea pig model of chronic obstructive pulmonary disease.
    Domínguez-Fandos D; Ferrer E; Puig-Pey R; Carreño C; Prats N; Aparici M; Musri MM; Gavaldà A; Peinado VI; Miralpeix M; Barberà JA
    Am J Respir Cell Mol Biol; 2014 Feb; 50(2):337-46. PubMed ID: 24032416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of airway inflammation and remodeling by muscarinic receptors: perspectives on anticholinergic therapy in asthma and COPD.
    Kistemaker LE; Oenema TA; Meurs H; Gosens R
    Life Sci; 2012 Nov; 91(21-22):1126-33. PubMed ID: 22406302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapeutic strategies for lung disorders associated with airway remodelling and fibrosis.
    Royce SG; Moodley Y; Samuel CS
    Pharmacol Ther; 2014 Mar; 141(3):250-60. PubMed ID: 24513131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new perspective on muscarinic receptor antagonism in obstructive airways diseases.
    Meurs H; Oenema TA; Kistemaker LE; Gosens R
    Curr Opin Pharmacol; 2013 Jun; 13(3):316-23. PubMed ID: 23643733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of airway remodeling.
    Hirota N; Martin JG
    Chest; 2013 Sep; 144(3):1026-1032. PubMed ID: 24008953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcholine beyond bronchoconstriction: roles in inflammation and remodeling.
    Kistemaker LE; Gosens R
    Trends Pharmacol Sci; 2015 Mar; 36(3):164-71. PubMed ID: 25511176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrins: therapeutic targets in airway hyperresponsiveness and remodelling?
    Wright DB; Meurs H; Dekkers BG
    Trends Pharmacol Sci; 2014 Nov; 35(11):567-74. PubMed ID: 25441775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic targets in lung tissue remodelling and fibrosis.
    Liu G; Philp AM; Corte T; Travis MA; Schilter H; Hansbro NG; Burns CJ; Eapen MS; Sohal SS; Burgess JK; Hansbro PM
    Pharmacol Ther; 2021 Sep; 225():107839. PubMed ID: 33774068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of matrix metalloproteinases in extracellular matrix remodelling in chronic obstructive pulmonary disease rat models].
    Li H; Cui D; Tong X; Ma N; Gao Y; Cui X; Lu L; Wang D; Liang Y
    Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):393-8. PubMed ID: 12137602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The non-neuronal cholinergic system as novel drug target in the airways.
    Pieper MP
    Life Sci; 2012 Nov; 91(21-22):1113-8. PubMed ID: 22982180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic receptor antagonists: effects on pulmonary function.
    Buels KS; Fryer AD
    Handb Exp Pharmacol; 2012; (208):317-41. PubMed ID: 22222705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.
    Hizawa N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1093-102. PubMed ID: 26089659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic M₃ receptors contribute to allergen-induced airway remodeling in mice.
    Kistemaker LE; Bos ST; Mudde WM; Hylkema MN; Hiemstra PS; Wess J; Meurs H; Kerstjens HA; Gosens R
    Am J Respir Cell Mol Biol; 2014 Apr; 50(4):690-8. PubMed ID: 24156289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regulation of bronchial tone in chronic obstructive pulmonary disease (COPD): role of muscarinic receptors].
    Abad Santos F; Novalbos J; Gallego Sandín S; Gálvez Múgica MA
    An Med Interna; 2003 Apr; 20(4):201-5. PubMed ID: 12768836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.